Biotech Leaders, Academics, and Policymakers Gather to Discuss Keys to Precision Medicine and 21st Century Cures

San Francisco, CA (March 23, 2015)- The Manhattan Institute’s Project FDA, in partnership with the University of California San Francisco, will host a public forum on the reforms necessary to accelerate the development of precision medicine technologies and strategies across both the public and private sectors

Some of America’s leading researchers, innovators, and public policy experts will convene on March 27 at the University of California San Francisco’s Mission Bay campus to discuss the potential of new data and technology platforms to develop customized care and cures and the challenges to be overcome to bring this powerful vision to fruition. Speakers include:

Atul Butte, Director, Institute for Computational Health Sciences, UCSF
Mark Fishman, President, Novartis Institutes for Biomedical Research
Jo Handelsman, Associate Director for Science, White House Office of Science and Technology Policy
Jonathan Hirsch, Founder & President, Syapse
Jeff Huber, Senior Vice President, Google X
Maynard Olson, Professor of Genome Sciences and of Medicine, Adjunct Professor of Computer Science & Engineering, University of Washington
Harold Paz, Executive Vice President and Chief Medical Officer, Aetna
Jennifer Puck, Professor, Departments of Immunology and Pediatrics, UCSF
Keith Yamamoto, Vice Chancellor for Research, UCSF; Executive Vice Dean, School of Medicine; Professor, Cellular & Molecular Pharmacology, UCSF

Panel discussion will be hosted by:
Michael Krasny, Host, KQED's Forum

The event is open to the public. Click here for more information and to register.